InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Humphrey David Carl, Chief Financial Officer. Officer active across 1 companies, notably Ensysce Biosciences, Inc.. Aggregated, 2 filings have been published. The latest transaction was filed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
050,000 shares0
Common Stock
SEC:0001493152-21-016123·
050,000 shares0
Common Stock
SEC:0001493152-21-016123:0·
2 of 2 declarations
About Humphrey David Carl
David Carl Humphrey is the Chief Financial Officer at Ensysce Biosciences, Inc. In this role, he oversees the financial operations of the company, which is active in the biopharmaceutical sector. Mr. Humphrey is responsible for financial management and strategy, contributing to the company's growth and sustainability.
